Immunotherapy: Who is Eligible?

Autor Wang, Daniel, Gilbert, Jill, Kim, Young J.
Vydáno v Otolaryngol Clin North Am (2017)

Factors Associated With the Career Choices of Hematology and Medical Oncology Fellows Trained at Academic Institutions in the United States

Autor Horn, Leora, Koehler, Elizabeth, Gilbert, Jill, Johnson, David H.
Vydáno 2011

Intracardiac Metastases Detected by (18)F-FSPG-PET

Autor Magarik, Meaghan, Walker, Ronald C, Gilbert, Jill, Manning, H Charles, Massion, Pierre P.
Vydáno v Clin Nucl Med (2018)

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Autor Argiris, Athanassios, Ghebremichael, Musie, Gilbert, Jill, Lee, Ju-Whei, Sachidanandam, Kamakshi, Kolesar, Jill M., Burtness, Barbara, Forastiere, Arlene A.
Vydáno 2013

A Phase I Trial of Erlotinib and Concurrent Chemoradiotherapy for Stage III and IV (M0) Squamous Cell Carcinoma of the Head and Neck

Autor Gilbert, Jill, Rudek, Michelle A., Higgins, Michaela J, Zhao, Ming, Bienvenu, Sara, Tsottles, Nancy, Wahl, Richard, Forastiere, Arlene, Gillison, Maura
Vydáno 2012

Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous c...

Autor Gilbert, Jill, Le Tourneau, Christophe, Mehanna, Hisham, Fayette, Jerome, Goswami, Trishna, Emeribe, Ugochi, Jarkowski, Anthony, Melillo, Giovanni, Siu, Lilian L
Vydáno v J Immunother Cancer (2015)

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

Autor Rodriguez, Paulo C., Hernandez, Claudia P., Quiceno, David, Dubinett, Steven M., Zabaleta, Jovanny, Ochoa, Juan B., Gilbert, Jill, Ochoa, Augusto C.
Vydáno 2005

A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy

Autor Zatarain, Lauren A., Smith, Derek K., Deng, Jie, Gilbert, Jill, Dietrich, Mary S., Niermann, Kenneth J., Ridner, Sheila H., Murphy, Barbara A.
Vydáno v Integr Cancer Ther (2018)

Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression i...

Autor Gilbert, Jill, Lee, Ju Whei, Argiris, Athanassios, Haigentz, Missak, Feldman, Lawrence Eric, Jang, Minyoung, Arun, Pattatheyil, Van Waes, Carter, Forastiere, Arlene A.
Vydáno 2012

The Impact of Secondary Lymphedema after Head and Neck Cancer Treatment on Symptoms, Functional Status, and Quality Of Life

Autor Deng, Jie, Murphy, Barbara A., Dietrich, Mary S., Wells, Nancy, Wallston, Kenneth A., Sinard, Robert J., Cmelak, Anthony J., Gilbert, Jill, Ridner, Sheila H.
Vydáno 2012

Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients

Autor Jackson, Leanne K., Ridner, Sheila H., Deng, Jie, Bartow, Carmin, Mannion, Kyle, Niermann, Ken, Gilbert, Jill, Dietrich, Mary S., Cmelak, Anthony J., Murphy, Barbara A.
Vydáno v J Palliat Med (2016)

A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/...

Autor Chung, Christine H., Rudek, Michelle A., Kang, Hyunseok, Marur, Shanthi, John, Pritish, Tsottles, Nancy, Bonerigo, Sarah, Veasey, Andy, Kiess, Ana, Quon, Harry, Cmelak, Anthony, Murphy, Barbara A., Gilbert, Jill
Vydáno v Oral Oncol (2015)

A Phase I Dose Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors

Autor Lin, Jianqing, Gilbert, Jill, Rudek, Michelle A., Zwiebel, James A., Gore, Steve, Jiemjit, Anchalee, Zhao, Ming, Baker, Sharyn D., Ambinder, Richard F., Herman, James G., Donehower, Ross C., Carducci, Michael A.
Vydáno 2009

A Phase 1 Study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinoma

Autor Galloway, Thomas, Wirth, Lori J., Colevas, Alexander D., Gilbert, Jill, Bauman, Julie E., Saba, Nabil F., Raben, David, Mehra, Ranee, Ma, Anna W., Atoyan, Ruzanna, Wang, Jing, Burtness, Barbara, Jimeno, Antonio
Vydáno v Clin Cancer Res (2015)

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Autor Goff, Laura W., Cardin, Dana B., Whisenant, Jennifer G., Du, Liping, Koyama, Tatsuki, Dahlman, Kimberly B., Salaria, Safia N., Young, Ruth T., Ciombor, Kristen K., Gilbert, Jill, Smith, Stephen James, Chan, Emily, Berlin, Jordan
Vydáno v Invest New Drugs (2016)

A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma

Autor Gilbert, Jill, Schell, Michael J., Zhao, Xiuhua, Murphy, Barbara, Tanvetyanon, Tawee, Leon, Marino E., Hayes, D. Neil, Haigentz, Missak, Saba, Nabil, Nieva, Jorge, Bishop, Justin, Sidransky, David, Ravi, Rajani, Bedi, Atul, Chung, Christine H.
Vydáno v Oral Oncol (2015)

Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients

Autor Chung, Christine H., Seeley, Erin H., Roder, Heinrich, Grigorieva, Julia, Tsypin, Maxim, Roder, Joanna, Burtness, Barbara A., Argiris, Athanassios, Forastiere, Arlene A., Gilbert, Jill, Murphy, Barbara, Caprioli, Richard M., Carbone, David P., Cohen, Ezra E.W.
Vydáno 2010

Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition

Autor Gallant, Jean-Nicolas, Sewell, Andrew, Almodovar, Karinna, Wang, Qingguo, Dahlman, Kimberly B., Abramson, Richard G., Kapp, Meghan E., Brown, Brandee T., Boyd, Kelli L., Gilbert, Jill, Cohen, Daniel N., Yarbrough, Wendell G., Zhao, Zhongming, Lovly, Christine M.
Vydáno v NPJ Precis Oncol (2019)

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Autor Argiris, Athanassios, Li, Shuli, Savvides, Panayiotis, Ohr, James P., Gilbert, Jill, Levine, Marshall A., Chakravarti, Arnab, Haigentz Jr, Missak, Saba, Nabil F., Ikpeazu, Chukwuemeka V., Schneider, Charles J., Pinto, Harlan A., Forastiere, Arlene A., Burtness, Barbara
Vydáno v J Clin Oncol (2019)

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

Autor Mehnert, Janice M., Varga, Andrea, Brose, Marcia S., Aggarwal, Rahul R., Lin, Chia-Chi, Prawira, Amy, de Braud, Filippo, Tamura, Kenji, Doi, Toshihiko, Piha-Paul, Sarina A., Gilbert, Jill, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D., Keam, Bhumsuk
Vydáno v BMC Cancer (2019)